Pre-seed and seed-stage fundraising in India increasingly relies on two instruments: the SAFE (Simple Agreement for Future Equity) and the convertible note. Both defer valuation to a future priced round, but their legal structures, tax implications, and conversion mechanics differ in important ways under Indian law. This guide clarifies the distinctions so founders and investors make informed choices.
Structural Comparison
| Feature | SAFE (& iSAFE) | Convertible Note |
|---|---|---|
| Legal nature | Agreement for future equity issuance | Debt instrument convertible to equity |
| Maturity date | None (converts at next qualified round) | 12–24 months (must convert or repay) |
| Interest rate | None | Typically 5–12% per annum |
| Valuation cap | Yes (or discount, or both) | Yes (plus discount, plus interest) |
| Board approval | Board resolution sufficient | Board + potentially shareholder approval |
| RBI compliance (foreign investors) | Complex—requires careful structuring | Covered under FEMA ECB regulations |
| iSAFE variant | India-specific, INR-denominated, compounding cap | N/A |
| Tax on conversion | Potentially exempt if structured correctly | Interest accrual taxable for investor |
Legal Nuances Under Indian Law
The core challenge with SAFEs in India is that they do not fit neatly into any category under the Companies Act, 2013. A SAFE is neither debt (no repayment obligation, no interest) nor equity (no shares issued at signing). This ambiguity creates potential issues with RoC filings, Foreign Exchange Management Act (FEMA) compliance for foreign investors, and tax characterisation.
The iSAFE—developed by 100X.VC—attempts to resolve some of these issues by denominating in INR, adding a compounding valuation cap, and structuring the instrument as a contractual right to future equity that aligns with Indian regulatory frameworks. However, even iSAFEs require careful legal review, particularly when foreign investors are involved.
Convertible notes, by contrast, have a clearer regulatory path. They are classified as debt instruments under the Companies Act and fall under FEMA’s External Commercial Borrowings (ECB) framework for foreign investors. This clarity makes them the preferred instrument when raising from US or Singapore-based angels and micro VCs.
Tax Implications
For the startup: SAFE proceeds are not treated as income at issuance. On conversion, if shares are issued at fair market value, no tax event occurs. Convertible note interest accrues as an expense on the startup’s P&L, providing a small tax shield but requiring cash or conversion at maturity.
For the investor: Interest earned on convertible notes is taxable as income. SAFE proceeds involve no periodic income, making them more tax-efficient for investors in high-tax jurisdictions. However, the conversion event’s tax treatment depends on the specific structure and the investor’s residency—always consult a tax advisor.
Which Should You Use?
Use a SAFE or iSAFE when: all investors are India-resident, you want a simple and fast instrument, and you are comfortable with the regulatory ambiguity. The iSAFE is particularly suitable for 100X.VC-style volume seed rounds.
Use a convertible note when: you have foreign investors, you want regulatory clarity, or your investors’ counsel insists on a debt instrument. Notes are also preferable when the fundraising process extends beyond 3 months, as the maturity date creates a forcing function.
For deeper understanding of term sheet clauses, read our term sheet guide. Also review our VC explainer for how these instruments fit into the broader funding journey.
Legal analysis reviewed against Companies Act 2013, FEMA 2024 amendments, and Income Tax Act provisions. Not legal advice. Analysis by VCW Editorial.